This report studies the global Procalcitonin (CAS 56645-65-9) market status and forecast, categorizes the global Procalcitonin (CAS 56645-65-9) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions. Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays. The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016, and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery. The manufacture region is concentrated in USA, Europe, China and Japan, of which Europe is the largest region with the share 36.92% in 2016. The production shares of Europe, China and Japan were 23.07%, 19.12% and 6.43%. The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. Asia Pacific is the main export region. There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in Procalcitonin market will become more intense. The global Procalcitonin (CAS 56645-65-9) market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The major manufacturers covered in this report Thermo Fisher Roche Diagnostics bioMerieux HyTest BBI Solutions ProSpec Wondfo Ningbo Medicalsystem Biotechnology Wuhan Easy Diagnosis Biomedicine Snibe Vazyme Biotech Getein Biotech Hotgen Biotech Lumigenex Nanjing Norman Biological Technology Shanghai Medicine'nest Pharmaceutical Kitgen Beijing KeyGen Beijing Apis Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan India Southeast Asia Other regions (Central & South America, Middle East & Africa) We can also provide the customized separate regional or country-level reports, for the following regions: North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Rest of Asia-Pacific Europe Germany France UK Italy Spain Russia Rest of Europe Central & South America Brazil Argentina Rest of South America Middle East & Africa Saudi Arabia Turkey Rest of Middle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Procalcitonin Antigen Procalcitonin Antibody By Application, the market can be split into Medical Industry Scientific Research The study objectives of this report are: To analyze and study the global Procalcitonin (CAS 56645-65-9) capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); Focuses on the key Procalcitonin (CAS 56645-65-9) manufacturers, to study the capacity, production, value, market share and development plans in future. Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. To define, describe and forecast the market by type, application and region. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Procalcitonin (CAS 56645-65-9) are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Procalcitonin (CAS 56645-65-9) Manufacturers Procalcitonin (CAS 56645-65-9) Distributors/Traders/Wholesalers Procalcitonin (CAS 56645-65-9) Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Procalcitonin (CAS 56645-65-9) market, by end-use. Detailed analysis and profiles of additional market players.
Table of Contents Global Procalcitonin (CAS 56645-65-9) Market Professional Survey Report 2018 1 Industry Overview of Procalcitonin (CAS 56645-65-9) 1.1 Definition and Specifications of Procalcitonin (CAS 56645-65-9) 1.1.1 Definition of Procalcitonin (CAS 56645-65-9) 1.1.2 Specifications of Procalcitonin (CAS 56645-65-9) 1.2 Classification of Procalcitonin (CAS 5664
